Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study
NCT ID: NCT04365764
Last Updated: 2023-04-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2020-03-14
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est
NCT04366206
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients
NCT04324047
Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19
NCT04359706
Host-pathogen Interactions During SARS-CoV-2 Infection
NCT04376476
Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
NCT06349707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Other outcomes of interest include: acute kidney injury, encephalopathy, need for intensive care unit transfers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposed to the treatment
Exposure variable will be studied treatment
No interventions assigned to this group
Not exposer to the treatment (control group)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients already hospitalized prior to study start date
* patients in palliative care
* lack of consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Intercommunal Robert Ballanger
OTHER
Centre Hospitalier Intercommunal Montfermeil-Le Raincy
UNKNOWN
CMC Ambroise Paré
OTHER
Groupe Hospitalier Pitie-Salpetriere
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lee S Nguyen
Study coordinator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joe-Elie Salem, MD, PhD
Role: STUDY_CHAIR
APHP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Intercommunal Robert Ballanger
Aulnay-sous-Bois, , France
Centre Hospitalier Intercommunal Le Raincy-Montfermeil
Montfermeil, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIC1421-20-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.